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  Herestraat	  49	  (UZ)	  -­‐	  bus	  902,	  3000	  Leuven,	  Belgium.	  	  The	   prohormone	   calcitriol	   has	   attracted	   the	   attention	   of	   many	  synthetic	   chemists	   as	   this	   hormone	  plays	   a	   crucial	   role	   in	  many	  cellular	   processes,	   and	   has	   been	   the	   lead	   structure	   for	   the	  development	   of	   a	   few	  potent	   drugs	   and	  drug	   candidates.	   	   Apart	  from	   its	   well-­‐known	   role	   in	   calcium-­‐	   and	   phosphate-­‐regulation,	  this	   steroid	  metabolite	   exhibits	   a	   remarkably	  broad	   spectrum	  of	  effects.	   Most	   notably,	   its	   unique	   property	   to	   both	   inhibit	   cell	  proliferation	   and	  promote	   cell	   differentiation	  has	  drawn	  a	   lot	   of	  interest	   for	  this	  prohormone	  as	  a	  possible	  small	  molecule-­‐based,	  non-­‐cytotoxic	   treatment	   for	   cancers.	   Moreover,	   the	   known	   drug	  target,	  the	  vitamin	  D	  receptor	  (VDR),	  is	  found	  in	  over	  30	  different	  tissues	  in	  the	  human	  body,	  including	  various	  tumours,	  opening	  up	  interesting	   therapeutic	   areas.	   However,	   the	   required	   supra-­‐physiological	  therapeutic	  doses	  of	  the	  natural	  hormone	  are	  highly	  toxic	  because	  of	  an	  acute	  hypercalcemic	  effect.	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III.	  Synthesis	  of	  ethyl	  A-­‐ring	  	  	  
We	   have	   developed	   a	   new	   route	   for	   2-­‐alkyl-­‐19-­‐nor-­‐analogues	   of	   calcitriol	  which	   is	   scalable	   and	   can	   be	   adapted	   to	  incorporate	   different	  moieties	   at	   the	   2-­‐position	   (a	  modi^ication	   often	   resulting	   in	   improved	   activity	   pro^iles).6	   The	  route	  starts	  from	  D-­‐(-­‐)-­‐quinic	  acid	  as	  a	  readily	  available	  chiral	  pool	  compound.	  Two	  analogues,	  contain	  respectively	  a	  2α-­‐methyl	   and	   2α-­‐ethyl	   group,	   were	   synthesized	   in	   suf^icient	   amounts	   to	   allow	   extensive	   biological	   tests	   (toxicity	  tests,	  in	  vitro	   	  af^inity	  screens	  and	  various	  disease	  models	  in	  mice).2	  Preliminary	  results	  have	  con^irmed	  the	  very	  low	  toxicity	  in	  mice	  (calcemic	  activity	  is	  less	  than	  2.5%	  compared	  to	  calcitriol),	  combined	  with	  a	  greatly	  enhanced	  effect	  on	  the	  in	  vitro	  growth	  of	  various	  cancer	  cell	  lines.	  De^inite	  results	  for	  the	  in	  vitro	  af^inity	  screens	  and	  in	  vivo	  mice	  models	  are	  under	  way.	  

































(a)	  pTsOH	  (cat.),	  MeOH,	  Δ,	  2	  h,	  (b)	  TBSCl,	  Et3N,	  DMF,	  0°C,	  overnight,	  (c)	  Dess-­‐Martin	  periodinane	  (1.5	  equiv.),	  NaHCO3,	  CH2Cl2	  ,	  3	  h,	  (d)	  Cp2TiCH2ClAlMe2,	  THF,	  -­‐78	  °C,	  2	  h,	  (e)	  NaBH4,	  EtOH,	  0	  °C	  to	  rt,	  overnight	  (f)	  NaIO4	  (aq.),	  MeOH,	  0	  °C,	  1	  h,	  (g)	  Me3SiCH2CO2Me,	  LDA,	  THF,	  -­‐78	  °C,	  2	  h,	  (h)	  Crabtree’s	  catalyst,	  iPrOH,	  H2,	  CH2Cl2,	  0	  °C,	  (i)	  iBu2AlH,	  CH2Cl2,	  -­‐78	  °C	  to	  rt,	  3	  h,	  (j)	  nBuLi,	  THF,	  0°C,	  30	  min;	  pTsCl,	  0	  °C,	  10	  min;	  LiPPh2,	  0	  °C,	  1	  h;	  H2O2,	  CH2Cl2,	  0	  °C	  to	  rt,	  30	  min.	  














f	  	  >99%	  g	  	  90%	  h	  	  77%	  





a)	  NaBH4,	  MeOH,	  0°C	  to	  rt,	  overnight,	  (b)	  benzaldehyde	  dimethylacetal,	  PPTS,	  CH2Cl2,	  40	  °C,	  22	  h,	  (c)	  BH3,	  THF,	  0	  °C	  to	  rt,	  1	  h;	  NaOH,	  H2O2,	  0	  °C	  to	  rt,	  1	  h,	  (d)	  Dess-­‐Martin	  periodinane	  (1.5	  equiv.),	  NaHCO3,	  CH2Cl2,	  rt,	  1	  h,	  (e)	  Ph3P=CH2,	  -­‐30	  °C	  to	  rt,	  2	  h,	  (f)	  Pd(OH)2/C,	  H2	  (1	  atm),	  EtOH,	  CH2Cl2,	  2	  h,	  (g)	  NaIO4,	  H2O,	  MeOH,	  0	  °C	  to	  rt,	  2	  h,	  (h)	  Me3SiCH2CO2Me,	  LDA,	  THF,	  -­‐78	  °C,	  2	  h,	  (i)	  iBu2AlH,	  CH2Cl2,	  -­‐78	  °C	  to	  rt,	  3	  h,	  (j)	  nBuLi,	  THF,	  0°C,	  30	  min;	  pTsCl,	  0	  °C,	  10	  min;	  LiPPh2,	  0	  °C,	  1	  h;	  H2O2,	  CH2Cl2,	  0	  °C	  to	  rt,	  30	  min.	  














IV.	  Conformational	  analysis	  via	  NOESY	  	  
d	  	  95%	   e,f	  	  95%	  (2	  steps)	  











































d,	  e 	  74%	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (2	  steps)	  	   	  	  	  	  	  	  	  	  
g 	  90%	  
3:2	  	  	  β:α	  	  NP-­‐HPLC	  
α	  β	  	  
S-­‐side	  chain	  
A-­‐ring	  
CD-­‐ring	  	   A	   solution	   to	   the	   toxicity	   problem	   lies	   in	   synthesizing	   analogues	  which	  can	  have	  a	  reduced	  hypercalcemic	  effect	  while	  retaining	  the	  anti-­‐proliferating	  and	  cell	  differentiating	  behaviour.	  Thus,	  already	  more	   than	  2000	  analogues	  have	  been	  produced.	  Various	  parts	  of	  this	   molecule	   have	   already	   been	   modi^ied	   (using	   SAR)	   and	  subsequently	  submitted	  for	  biologic	  tests.	  In	   more	   recent	   studies,	   potent	   2-­‐alkyl-­‐analogues	   emerged2	   as	  compounds	  with	  a	  very	  large	  dissociation	  of	  toxic	  and	  therapeutic	  effects	   in	   preliminary	   in	   vitro	   af^inity	   assays	   and	   in	   vivo	   tests	   in	  mice.	  Therefore,	  the	  aim	  of	  this	  project	  was	  to	  develop	  a	  new	  and	  more	  versatile	  route	   for	   these	  analogues	  to	  allow	  more	  extensive	  tests	   in	   animal	   models	   of	   various	   deseases	   (the	   ^irst	   generation	  ‘discovery’	   route	   only	   afforded	   sub-­‐mg	   amounts	   of	   these	  promising	  analogues).	  
I.	  Introduction	  	  	  
i	  	  80%	  
V.	  Synthesis	  of	  analogues	  	  
i.  nBuLi,	  THF,	  5	  min,	  -­‐78°C	  ii.  adding	  CD-­‐ketone,	  -­‐78°C	  
MeOH,	  1%	  HCl	  aq.	  	  99%	  	  
Calcitriol:	  Photochemically	  and	  metabolically	  converted	  from	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7-­‐dehydrocholesterol	  via	  sunlight	  radiation	  and	  uptake	  from	  fat	  ^ish,	  mushrooms,	  eggs,	  …	  	  
BINDING	  AFFINITY	   IN	  VITRO	   IN	  VIVO4	  
HL-­‐60	   MG-­‐63	  MCF-­‐7	   KERAT.	  	  	  	   PBMC	  
VI.	  Testing	  for	  Biological	  Activity	  
VIII.	  Conclusion	  
-­‐19nor-­‐14,20epi-­‐23-­‐yne-­‐(1α,25)-­‐calcitriol	  2α-­‐ethyl	  2α-­‐methyl	  
(5	  steps	  from	  D2)	  
2Me-­‐analogue,	  1	   	  	  2Et-­‐analogue,	  	  2 	  	  	  









14	  steps	  11.8%	  overall	   14	  steps	  7.0%	  overall	  
Toxicity	  in	  mice	  (7	  days	  treatment)	  Calcium	  in	  serum,	  	  Urine,	  bone	  Osteocalcin	  	  Osteocalcin	  	  [3H]Thymidine	  incorporation	  assay	  Nitroblue	  Tetrazolium	  assay	  














HL-60 MCF-7 HL-60 MCF-7 
calcitriol 100 100 100 1 1 
Me-analogue 1 1500 4500 4 375 1125 
Et-analogue  2 400 1500 1 400 1500 
In	  vitro	  and	  in	  vivo	  activities	  are	  now	  under	  investigation	  by	  the	  group	  of	  A.	  Verstuyf.	  	  
Convenient	  and	  versatile	  route	  to	  2-­‐alkyl-­‐19-­‐nor-­‐analogues	  of	  calcitriol	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